The Harvard Drug Group LLC, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 6,997 cartons of Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg). The medication was found to fail dissolution specifications, meaning it may not release the active ingredient properly into the patient's system. The affected tablets are used to treat low potassium levels and are sold in cartons of 100 tablets using unit-dose blisters.
If the medication does not dissolve correctly, the drug may not be absorbed at the intended rate, potentially leading to ineffective treatment of low potassium levels (hypokalemia). This could result in an electrolyte imbalance in the body.
You have 2 options:
10 x 10 unit dose blisters; Distributed by Aurobindo Pharma USA, INC. and MAJOR PHARMACEUTICALS.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.